| Literature DB >> 33490909 |
Rita Teixeira-Santos1, Marisa Gomes1, Luciana C Gomes1, Filipe J Mergulhão1.
Abstract
Although high-performance carbon materials are widely used in surface engineering, with emphasis on carbon nanotubes (CNTs), the application of CNT nanocomposites on medical surfaces is poorly documented. In this study, we aimed to evaluate the antimicrobial and anti-adhesive properties of CNT-based surfaces. For this purpose, a PRISMA-oriented systematic review was conducted based on predefined criteria and 59 studies were selected for the qualitative analysis. Results from the analyzed studies suggest that surfaces containing modified CNTs, and specially CNTs conjugated with different polymers, exhibited strong antimicrobial and anti-adhesive activities. These composites seem to preserve the CNT toxicity to microorganisms and promote CNT-cell interactions, as well as to protect them from nonspecific protein adsorption. However, CNTs cannot yet compete with the conventional strategies to fight biofilms as their toxicity profile on the human body has not been thoroughly addressed. This review can be helpful for the development of new engineered medical surfaces.Entities:
Keywords: Microfilms; Surface Science
Year: 2020 PMID: 33490909 PMCID: PMC7809508 DOI: 10.1016/j.isci.2020.102001
Source DB: PubMed Journal: iScience ISSN: 2589-0042
Figure 1Antimicrobial activity of CNTs
(A) List and schematic representation of the mechanisms of action of CNTs against bacteria. The main mechanism consists of physically piercing the microorganisms' outer membranes, leading to membrane damage and release of cellular components. Other modes of action include the generation of reactive oxygen species (ROS) and oxidative stress that can damage and destroy cellular components such as DNA and proteins, resulting in cell death.
(B) Factors that may affect the antimicrobial performance of CNTs associated with their inherent properties and the characteristics of the target microorganisms.
Figure 2Summary of the literature search based on the PRISMA flowchart (Moher et al., 2009)
Figure 3Number of published studies addressing the antimicrobial and anti-adhesive properties of carbon nanotubes with application in the medical field, by year
Studies demonstrating the antimicrobial efficacy of functionalized carbon nanotubes with application in the medical field
| Functionalized CNTs | Type | Medical application | Species | Major conclusions | Reference |
|---|---|---|---|---|---|
| Pulsed laser deposition of graphite and bombardment of nitrogen ions | MWCNT | Medical devices | ( | ||
| Surface groups | MWCNT | Orthopedic applications | Bacteria exposed to f-MWCNT composites showed lower optical density compared with control (p < 0.01) | ( | |
| Ethanolamine | MWCNT | Antimicrobial agents | A broad range of Gram-positive and -negative bacteria | Based on MIC determination, the antimicrobial activity of f-MWCNTs was higher than p-MWCNTs (2.87 ± 0.11–14.22 ± 0.17 μg/mL versus 6.12 ± 0.16–36.41 ± 0.06 μg/mL) | ( |
| Surface groups | MWCNT | Medical devices | The percentage of killed bacteria in f-MWCNT membranes was over 98% | ( |
MWCNT, multi-walled carbon nanotubes; MIC, minimum inhibitory concentration.
Studies reporting the efficacy of single- and multi-walled CNTs conjugated with compounds displaying antimicrobial activity
| CNT-antimicrobial compounds | Type | Medical application | Species | Major conclusions | Reference |
|---|---|---|---|---|---|
| Cefalexin | MWCNT | Nonspecified | MWCNT/cefalexin films reduced bacteria viability by 50%–80% | ( | |
| AZ | SWCNT | Drug delivery | SWCNT/AZ composites had a significant | ( | |
| Rifampicin | MWCNT | Implant materials | MWCNT/rifampicin-coated surfaces caused a significant inhibition of biofilm formation for up to 5 days (50%) | ( | |
| APT | SWCNT | Nonspecified | A high reduction of bacterial growth (≈90%) was observed when bacteria were exposed to porphyrin-SWCNT composite | ( | |
| DTTC fluorophores | MWCNT | Nonspecified | ( | ||
| EP | MWCNT | Medical devices | MWCNT/EP composites killed 97.6%, 91.5%, and 88.5% of | ( | |
| PLL and PGA | SWCNT | Medical devices | SWCNT/AMP films inactivated | ( | |
| Nisin | MWCNT | Antimicrobial surfaces | MWCNT/nisin composites showed up to 7-fold higher antimicrobial activity than p-MWCNTs. Additionally, deposited films exhibited a 100-fold higher anti-biofilm activity than the p-MWCNT deposited film | ( | |
| LSZ | SWCNT | Medical devices | Coatings terminating in SWNT/LSZ layer exhibited an antimicrobial activity of 84% | ( | |
| Lysostaphin | MWCNT | Antimicrobial surfaces | Enzyme-based composites were highly efficient in killing MRSA (> 99%) | ( | |
| Laccase | MWCNT | Antimicrobial surfaces | The laccase-CNT films showed > 99% bactericidal activity against | ( | |
APT, antimicrobial photodynamic therapy; AMP, antimicrobial peptide; APT, amine-functionalized porphyrin; AZ, azithromycin; DTTC, 3,3′-diethylthiatricarbocyanine; EP, epsilon-polylysine; LSZ, lysozyme; MWCNT, multi-walled carbon nanotubes; PGA, poly(L-glutamic acid); PLL, polyelectrolytes poly(L-lysine); MRSA, MRSA, methicillin-resistant Staphylococcus aureus; NIR, near-infrared; SWCNT, single-walled carbon nanotubes.
Figure 4Synergic effect of antimicrobial compounds, metals, and polymers associated with carbon nanotubes
Studies reporting the efficacy of single- and multi-walled CNTs conjugated with silver and other metals
| CNT-metals | Type | Medical application | Species | Major conclusions | Ref. |
|---|---|---|---|---|---|
| AgNPs stabilized with DNA | SWCNT | Drug delivery | A broad range of Gram-positive and -negative bacteria | The bactericidal ratio of the AgNP-nanofilm against the major pathogenic organisms was between 57.78% and 78.89% | ( |
| AgNPs | MWCNT | Medical devices | Bacteria viability on the Ag-CNT films decreased by 32% and 13% for | ( | |
| SWCNT | Nonspecified | The number of bacteria colonies decreased by 4 log in the presence of Ag-CNT hybrid films | ( | ||
| MWCNT | Medical implants | Polymer shielded with AgNP-CNT inactivated | ( | ||
| MWCNT | Medical devices | The Ag- plasma polymer fluorocarbon nanocomposite films suppressed the growth and proliferation of bacteria by up 92.2% compared with uncoated films | ( | ||
| Zn-HA | MWCNT | Bioimplants | Bacterial growth was clearly inhibited by Zn-HA-MWCNT (inhibition zone ≥12 mm) | ( | |
| PdNPs | MWCNT | Nonspecified | PdNP-MWCNT composites deposited in a polypyrrole matrix showed 65–81.71% biofilm inhibition | ( |
AgNPs, silver nanoparticles; MWCNT, multi-walled carbon nanotubes; PdNPs, palladium nanoparticles; SWCNT, single-walled carbon nanotubes; Zn-HA, Zinc-hydroxyapatite.
Studies reporting the efficacy of single- and multi-walled CNTs conjugated with polymers
| CNT-Polymer composites | Type | Medical application | Species | Major conclusions | Reference |
|---|---|---|---|---|---|
| PLGA | SWCNT | Medical devices | Up to 98% bacteria were inactivated on SWCNT/PLGA versus 15%–20% on pure PLGA | ( | |
| PEI | MWCNT | Medical devices | Almost no adhered | ( | |
| Poly(ester amide) | MWCNT | Wound dressing | Nanocomposites exhibited high antibacterial efficacy against | ( | |
| PEG | MWCNT | Wound dressing | CNT/PEG-grafted polyurethane/electrospun nanofibers reduced adherent bacteria by 85.3% | ( | |
| MWCNT | Tissue engineering of bone or cartilage | Gram-positive and -negative bacteria | The inhibition zone for drug-loaded c-MWCNT-PEG/gelatin-CS nanocomposite was higher against all the bacterial species compared with drug-loaded c-MWCNT/gelatin-CS composite | ( | |
| PE | MWCNT | Nonspecified | After 56 days of biofilm growth, the number of cells for the 4% MWCNT/PE composites decreased by 89.3% for | ( | |
| Lignin in PVA | MWCNT | Wound healing | After 18 h of incubation with the lignin/PVA and lignin/t-MWCNT/PVA NFs, bacterial growth decreased by 60% and 69%, respectively, compared with the control | ( | |
| PMMA | MWCNT | Dental biomaterials | Compared with the PMMA control group, the CNT/PMMA composites showed a significant decrease in microbial adhesion (35%–95% less adhesion) by all three microbial species | ( | |
| PNIPAM hybrid brush | SWCNT | Nonspecified | CNT/PNIPAM films showed > 85% bacterial inactivation | ( | |
| PVK | MWCNT | Nonspecified | The MWCNT/PVK- and MWNT-modified substrates inhibited bacterial growth by up to 83% and 87%, respectively | ( | |
| Polypyrrole | MWCNT | Wound dressing | The anti-biofilm activity is field-dependent, reaching a reduction of 40% for | ( | |
| CS | MWCNT | Nonspecified | CNT/CS hydrogels showed a strong antimicrobial activity (∼1 log reduction, except for Gram-negative bacteria) | ( | |
| MWCNT | Drug delivery | Bacterial killing efficacy of Ag-MWCNT/biopolymer composites was above 80% | ( | ||
| MWCNT | Nonspecified | MWCNT/CMCS biocomposites exhibited high inhibition zone diameters: 22.3 ± 0.21 mm against | ( | ||
| MWCNT | Nonspecified | MWCNT/aminohydrazide cross-linked CS composites displayed high antimicrobial activity as demonstrated by their inhibition zones for bacteria (≥18.4 ± 0.20 mm) and fungi (≥17.2 ± 0.45 mm) | ( | ||
| MWCNT | Nonspecified | MWCNT/aminosalicylhydrazide cross-linked CS composites displayed high antimicrobial activity as judged by their inhibition zones for bacteria (> 19.8 ± 0.20 mm) and fungi (> 20.1 ± 0.20 mm) | ( | ||
| MWCNT | Nonspecified | Gram-positive and -negative bacteria; Fungi | MWCNT/trimellitic anhydride isothiocyanate cross-linked CS hydrogel composites showed high antimicrobial activity as demonstrated by their inhibition zones for bacteria (≥16.7 ± 0.50 mm) and fungi (≥18.4 ± 0.63 mm) | ( | |
| MWCNT | Drug delivery | The number of adhered cells in the hydrogel decreased sharply (4 log reduction) by the incorporation of CS-MWCNT | ( |
CS, chitosan; CMCS, carboxymethyl chitosan; MWCNT, multi-walled carbon nanotubes; PE, polyethylene; PEG, Polyethylene glycol; PEI, poly(ethyleneimine); PLGA, poly(lactic-co-glycolic acid); PVA, poly(vinyl alcohol); PMMA, poly(methyl methacrylate); PNIPAM, poly(N-isopropylacrylamide); PVK, poly(N-vinylcarbazole); SWCNT, single-walled carbon nanotubes.
Promising CNT composite solutions for medical applications
| CNT composites | Type | Medical application | Species | Major conclusions | Reference |
|---|---|---|---|---|---|
| Heteroatoms (N, F, P/B) | MWCNT | Wound healing | f-MWCNT showed 82.53%, 80.98%, 76.83%, and 77.41% biofilm inhibition against | ( | |
| Sodium cholate | SWCNT | Antimicrobial agents | Antibacterial effect increased with increasing SWCNT concentration as demonstrated by the optical density reduction from 0.8 to 0.4 | ( | |
| Rose Bengal (RB) | MWCNT | Antimicrobial agents | RB-CNT-mediated photodestruction resulted in 5.46 log reduction for | ( | |
| Malachite green (MG) | MWCNT | Medical devices | Upon MG-c-MWCNT treatment, | ( | |
| Methylene blue (MB) | MWCNT | Medical devices | Photodynamic activation of MB-c-MWCNT resulted in 4.86 and 5.55 log reductions in | ( | |
| Toluidine blue (TB) | MWCNT | Medical devices | ( | ||
| AMPs: TP359, TP226, and TP557 | SWCNT | Antimicrobial agents | Non-treated 3D skin showed 4 log CFU/g increase in 2 h after incubation with bacteria, whereas the f-SWCNT-s-Ag-treated skin showed only 1 log CFU/g increase in bacterial counts | ( | |
| Silver nanoparticles-deposited f-CNT with an amphiphilic poly(propyleneimine) dendrimer | MWCNT | Drug delivery | f-MWCNTs-AgNPs showed an inactivation percentage of 99.8% ± 0.2%, 99.7% ± 0.1%, and 93.1% ± 0.5%, for | ( | |
| Silver sulfide quantum dots (Ag2S) | MWCNT | Antimicrobial surfaces | The bacteria killing ability of f-MWCNT-Ag2S was 97.8% ± 2.1%, 78.5% ± 2.9%, and 55.7% ± 1.5% for | ( | |
| AgNP-decorated c-CNT | MWCNT | Nonspecified | Ag-MWCNT (40 or 50 μg/mL) completely inhibited bacterial growth | ( | |
| Silver and copper nanoparticles | MWCNT | Medical devices | Ag-MWCNT and Cu-MWCNT exhibited 97% and 89% growth inhibition against | ( | |
| Copper nanoparticles | MWCNT | Nonspecified | Gram-positive and -negative bacteria; Fungi | Cu-MWCNT showed an enhanced inhibitory effect when compared with MWCNT | ( |
| Titanium oxide-gold (TiO2-Au) | MWCNT | Drug delivery | A broad range of Gram-positive and -negative bacteria | More than 90% biofilm inhibition was observed in the presence of TiO2-Au-MWCNT | ( |
| Titanium dioxide (TiO2) | MWCNT | Antimicrobial agents | TiO2-MWCNT displayed high antimicrobial activity against both bacteria, as demonstrated by the diameter of inhibition zones (≥18 mm) | ( | |
| Cadmium quantum dots (CdS) | MWCNT | Antimicrobial agents | The bacteria-killing ability of f-MWCNT-CdS was 87.2% ± 4.1%, 68.9% ± 2.5%, and 46.7% ± 1.4% against | ( | |
| Amphiphilic poly(propyleneimine) | MWCNT | Drug delivery | MWCNTs-APPI hybrid inhibited bacterial growth by 96.6% ± 0.3%, 96.5% ± 0.2%, and 87% ± 0.5% for | ( | |
| Antibodies to group A | MWCNT | Antimicrobial agents | GAS-MWCNT induced 97%–100% killing of planktonic cells, depending on the time of laser exposure, and 99.99% killing of bacteria in biofilm | ( | |
| Pyrazole and pyrazolone derivates | MWCNT | Antimicrobial agents | The antibacterial activity of MWCNTs conjugated with pyrazole derivates ranged between 17.5% and 95.2% | ( | |
| Mannose derivates | SWCNT | Anti-adhesive agents | Uropathogenic | Mannose derivate-SWCNT induced a considerable reduction in the CFU (around 50%) when compared with the control | ( |
APT, antimicrobial photodynamic therapy; AMP, antimicrobial peptide; MWCNT, multi-walled carbon nanotubes; SWCNT, single-walled carbon nanotubes; CFU, colony forming unit.